Regeneron Pharmaceuticals, Inc.

VOLORIDGE INVESTMENT MANAGEMENT, LLC REGN

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

172,836

Value ($000)

97,180

Weight

0.3%

2020 Q1 - 2025 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	97,180	0.3%	172,836	9/30/2025
2025 Q2	8/14/2025	146,927	0.5%	279,860	6/30/2025
2025 Q1	5/15/2025	144,776	0.5%	228,270	3/31/2025
2024 Q4	2/14/2025	151,105	0.5%	212,128	12/31/2024
2023 Q4	2/14/2024	29,167	0.1%	33,209	12/31/2023
2023 Q3	11/14/2023	26,836	0.1%	32,609	9/30/2023
2023 Q2	8/14/2023	13,155	0.1%	18,308	6/30/2023
2023 Q1	5/15/2023	10,554	0.1%	12,844	3/31/2023
2022 Q4	2/14/2023	4,339	0.0%	6,014	12/31/2022
2021 Q4	2/14/2022	1,634	0.0%	2,588	12/31/2021
2021 Q3	11/15/2021	14,702	0.1%	24,293	9/30/2021
2021 Q2	8/16/2021	1,087	0.0%	1,947	6/30/2021
2020 Q4	2/16/2021	20,868	0.2%	43,195	12/31/2020
2020 Q3	11/16/2020	82,098	0.7%	146,661	9/30/2020
2020 Q2	8/14/2020	50,744	0.6%	81,366	6/30/2020
2020 Q1	5/15/2020	4,513	0.1%	9,242	3/31/2020